Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis
Journal of Bone and Joint Surgery · 2023
DOI: 10.2106/jbjs.23.00251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2023. Verfasst von Shiraz A Sabah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Knee Prosthesis, Arthritis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The purpose of this study was to investigate patient-relevant outcomes following first revision total knee arthroplasties (rTKAs) performed for different indications.
Methods
This population-based cohort study utilized data from the United Kingdom National Joint Registry, Hospital Episode Statistics Admitted Patient Care, National Health Service Patient-Reported Outcome Measures, and the Civil Registrations of Death. Patients undergoing a first rTKA between January 1, 2009, and June 30, 2019, were included in our data set. Patient-relevant outcomes included implant survivorship (up to 11 years postoperatively), mortality and serious medical complications (up to 90 days postoperatively), and patient-reported outcome measures (at 6 months postoperatively).
Results
A total of 24,540 first rTKAs were analyzed. The patient population was 54% female and 62% White, with a mean age at the first rTKA of 69 years. At 2 years postoperatively, the cumulative incidence of re-revision surgery ranged from 2.7% (95% confidence interval [CI], 1.9% to 3.4%) following rTKA for progressive arthritis to 16.3% (95% CI, 15.2% to 17.4%) following rTKA for infection. The mortality rate at 90 days was highest following rTKA for fracture (3.6% [95% CI, 2.5% to 5.1%]) and for infection (1.8% [95% CI, 1.5% to 2.2%]) but was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England.
- Nuffield Orthopaedic Centre, Oxford, England.
- Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, England.
- Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, United Kingdom.
- Nuffield Department of Primary Care Health Sciences, Oxford, England.
ORCID-Profile: Shiraz A Sabah, Ruth Knight, Antony J R Palmer, Robert Middleton, Simon G F Abram, Sally Hopewell, Stavros Petrou, David J Beard, Andrew J Price
Zitieren
APA
Sabah, S. A., Knight, R., Alvand, A., Palmer, A. J. R., Middleton, R., Abram, S. G. F., Hopewell, S., Petrou, S., Beard, D. J., & Price, A. J. (2023). Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.23.00251
Vancouver
Sabah SA, Knight R, Alvand A, Palmer AJR, Middleton R, Abram SGF, et al. Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis. Journal of Bone and Joint Surgery. 2023. doi:10.2106/jbjs.23.00251
BibTeX
@article{Sabah2023,
author = {Sabah, Shiraz A and Knight, Ruth and Alvand, Abtin and Palmer, Antony J R and Middleton, Robert and Abram, Simon G F and Hopewell, Sally and Petrou, Stavros and Beard, David J and Price, Andrew J},
title = {Patient-Relevant Outcomes Following First Revision Total Knee Arthroplasty, by Diagnosis},
journal = {Journal of Bone and Joint Surgery},
year = {2023},
doi = {10.2106/jbjs.23.00251}
}
EUVIMED